CHRS: Coherus BioSciences, Inc. Stock

by  •  • Comments Off on CHRS: Coherus BioSciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 91.67
Enterprise Value ($M) 274.68
Book Value ($M) -183.47
Book Value / Share -1.58
Price / Book -0.50
NCAV ($M) -267.20
NCAV / Share -2.31
Price / NCAV -0.34

Profitability (mra)
Return on Invested Capital (ROIC) -1.51
Return on Assets (ROA) -0.17
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.92
Current Ratio 1.94

Balance Sheet (mrq) ($M)
Current Assets 287.34
Assets 371.07
Liabilities 554.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 266.96
Operating Income -105.00
Net Income 28.51
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.44
Cash from Investing 230.32
Cash from Financing -186.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-17 13G/A BlackRock, Inc. 6.60 -31.22
04-16 13G Satterfield Thomas A Jr 5.20
02-13 13G/A Rubric Capital Management LP 4.56 -49.44
07-23 13G/A Temasek Holdings (Private) Ltd 4.80 -10.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-04 371,283 1,184,482 31.35
2025-06-03 587,368 1,751,399 33.54
2025-06-02 340,269 862,620 39.45
2025-05-30 191,162 594,530 32.15

(click for more detail)

Similar Companies
BTMD – biote Corp. CADL – Candel Therapeutics, Inc.
CARM – Carisma Therapeutics, Inc. CLSD – Clearside Biomedical, Inc.
CLYM – Climb Bio, Inc.


Financial data and stock pages provided by
Fintel.io